Trial Profile
Clinical trial of AMZ 0026 in patients with HIV-1 infections who are receiving highly active antiretroviral therapy (HAART).
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2012
Price :
$35
*
At a glance
- Drugs AMZ 0026 (Primary) ; Antivirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Mar 2012 Profile title is not an official title; phase is guessed. Information received in a Clinical development update from Amazon biotech (dated March 2012)
- 20 Mar 2012 New trial record